Glaucoma

Lancet

Volumn 354, Issue 9192, 1999, Pages 1803-1810

  Coleman, Anne L ^a  

^a Glaucoma Division   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; ADRENALIN; APRACLONIDINE; BETAXOLOL; BRIMONIDINE; BRINZOLAMIDE; CARBACHOL; CARTEOLOL; DEMECARIUM; DICLOFENAMIDE; DIPIVEFRINE; DORZOLAMIDE; ECOTHIOPATE IODIDE; LATANOPROST; LEVOBUNOLOL; METHAZOLAMIDE; METIPRANOLOL; PILOCARPINE; TIMOLOL;

ANXIETY NEUROSIS; BLINDNESS; BLOOD DYSCRASIA; CARDIOTOXICITY; CLINICAL TRIAL; CLOSED ANGLE GLAUCOMA; CONFUSION; DEPRESSION; DEVELOPED COUNTRY; DRIVING ABILITY; DRUG HYPERSENSITIVITY; EARLY DIAGNOSIS; EYE TOXICITY; GASTROINTESTINAL SYMPTOM; GLAUCOMA; GLAUCOMA SURGERY; HEALTH EDUCATION; HUMAN; HYPERTRICHOSIS; IMPOTENCE; INTRAOCULAR PRESSURE; MYASTHENIA GRAVIS; MYOPIA; NEUROTOXICITY; OPEN ANGLE GLAUCOMA; OPTIC DISK; OPTIC NERVE DISEASE; ORAL DRUG ADMINISTRATION; PATIENT CARE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SOCIAL INTERACTION; TOPICAL DRUG ADMINISTRATION; VISUAL IMPAIRMENT;

EID: 0033589732     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)04240-3     Document Type: Review

References (86)

1. The International Bank for Reconstruction and Development/the World Bank: World Development Report 1993. Oxford: Oxford University Press, 1993.
2. Quigley H.A. Number of people with glaucoma worldwide. Br J Ophthalmol. 80:1996;389-393.
3. Tielsch J.M., Sommer A., Katzet al. Racial variation in the prevalence of primary open angle glaucoma: the Baltimore Eye Survey. JAMA. 266:1991;369-374.
4. Glynn R.J., Seddon J.M., Krug J.H., Sahagian C.R., Chiavelli M.R., Campion E.W. Falls in elderly patients with glaucoma. Arch Ophthalmol. 109:1991;205-210.
5. Owsley C., McGwin G., Ball K. Vision impairment, eye disease, and injurious motor vehicle crashes in the elderly. Ophthalmic Epidemiol. 5:1998;101-113.
6. Wilson M.R., Coleman A.L., Bing E.G.et al. Functional status and well being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 Questionnaire. Ophthalmology. 105:1998;2112-2116.
7. Sherwood M.B., Garcia-Siekavizza A., Meltzer M.I.et al. Glaucoma's impact on quality of life and its relation to clinical indicators. A pilot study. Ophthalmology. 105:1998;561-566.
8. Gutierrez P., Wilson M.R., Johnson C.et al. Influence of glaucomatous visual field loss on health-related quality of life. Arch Ophthalmol. 115:1997;777-784.
9. Parrish R.K. II, Gedde J.J., Scott I.U.et al. Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 115:1997;1447-1455.
10. Nelson P., Aspinall P., O'Brein C. Patients' perception of visual impairment in glaucoma: a pilot study. Br J Ophthalmol. 83:1999;546-552.
11. Preferred practice pattern of primary open angle glaucoma. 1996;American Academy of Ophthalmology, San Francisco.
12. European Glaucoma Society. Terminology and guidelines for European Glaucoma Society, Savona, Italy: Dogma Srl. 1998.
13. Quigley H.A., Vitae S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 38:1997;83-91.
14. Sommer A., Tielsch J.M., Katz J.et al. Relationship between intraocular pressure and primary open angle glaucoma among white and black Americans. Arch Ophthalmol. 109:1991;1090-1095.
15. Quigley H.A., Katz J., Derick R.J., Gilbert D., Sommer A. An evaluation of optic dis and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology. 99:1992;19-28.
16. Quigley H.A. Current and future approaches to glaucoma screening. J Glaucoma. 7:1998;210-220.
17. Tjon-Fo, Sang MJ, Lemij HG. The sensitivity and specificity of nerve fibre layer measurements in glaucoma as determined with scanning laser polarimetry. Am J Ophthalmol 1997; 123: 62-69.
18. Tielsch J.M., Katz J., Singh K.et al. A population-based evaluation of glaucoma screening: the Baltimore eye survey. Am J Epidemiol. 134:1991;1102-1110.
19. Sponsel W.E., Ritch R., Stamper R.et al. Prevent blindness America visual field screening study. Am J Ophthalmol. 120:1995;699-708.
20. Quigley H.A., Nickells R.W., Kerrigan L.A.et al. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthal Vis Sci. 36:1995;774-786.
21. Dreyer E.B., Lipton S.A. New perspectives on glaucoma. JAMA. 281:1999;306-308.
22. Quigley H.A., Addicks E.M. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci. 19:1980;137-152.
23. Cartwright M.J., Anderson D.R. Correlation of asymmetric damage with asymmetric intraocular pressure in normal tension glaucoma. Arch Ophthalmol. 106:1988;898-900.
24. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol. 126:1998;487-497.
25. The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma. Am J Ophthalmol. 126:1998;498-505.
26. Leske M.C., Connell A.M.S., Schachat A.P.et al. The Barbados Eye Study: prevalence of open angle glaucoma. Arch Ophthalmol. 112:1994;821-829.
27. Mason R.P., Kosoko O., Wilson M.R.et al. National survey of the prevalence and risk factors of glaucoma in St Lucia, West Indies: part I, prevalence findings. Ophthalmology. 96:1989;1363-1368.
28. Mitchell P., Smith W., Attebo K., Healey P.R. Prevalence of open-angle glaucoma in Australia: the Blue Mountains Eye Study. Ophthalmology. 103:1996;1661-1669.
29. Shiose Y., Kitazawa Y., Tsukahara S.et al. Epidemiology of glaucoma in Japan: a nationwide glaucoma survey. Jpn J Ophthalmol. 35:1991;133-155.
30. Klein B.E., Klein R., Sonsel W.E.et al. Prevalence of glaucoma. The Beaver Dam Eye Study. Ophthalmology. 99:1992;1499-1504.
31. Coffey M., Reidy A., Wormald R.et al. Prevalence of glaucoma in the west of Ireland. Br J Ophthalmol. 77:1993;17-21.
32. Dielemans I., Vingerling J.R., Wolfs R.C.et al. The prevalence of primary open angle glaucoma in a population-based study in The Netherlands. The Rotterdam Study. Ophthalmology. 101:1994;1851-1855.
33. Wensor M.D., McCarty C.A., Stanislavsky Y.L., Livingston P.M., Taylor H.R. The prevalence of glaucoma in the Melbourne Visual Impairment Project. Ophthalmology. 105:1998;733-739.
34. Tielsch J.M., Katz J., Sommer A., Quigley H.A., Javitt J.C. Family history and risk of primary open angle glaucoma: the Baltimore Eye Survey. Arch Ophthalmol. 112:1994;69-73.
35. Wolfs R.C.W., Klaver C.C.W., Ramrattan R.S., Van Duijn C.M., Hofman A., de Jong P.T.V.M. Genetic risk of primary open glaucoma. Arch Ophthalmol. 116:1998;1640-1645.
36. Tielsch J.M., Katz J., Quigley H.A., Javitt J.C., Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology. 102:1995;48-53.
37. Klein B.E.K., Klein R., Jensen S.C. Open-angle glaucoma and older-onset diabetes: the Beaver Dam Eye Study. Ophthalmology. 101:1994;1173-1177.
38. Mitchell P., Smith Wayne, Chey T., Healey P.R. Open-angle glaucoma and diabetes: the Blue Mountain Eye Study, Australia. Ophthalmology. 104:1997;712-718.
39. Leske M.C., Connel A.M.S., Wu S., Hyman L.G., Schachat A.P. Risk factors for open-angle glaucoma: the Barbados Eye Study. Arch Ophthalmol. 113:1995;918-924.
40. Tielsch J.M., Katz J., Sommer A., Quigley H.A., Javitt J.C. Hypertension, perfusion pressure and primary open-angle glaucoma: a population-based assessment. Arch Ophthalmol. 113:1995;216-221.
41. Dielemans I., Vingerling J.R., Algra D.et al. Primary open-angle glaucoma, intraocular pressure, and systemic blood pressure in the general elderly population: the Rotterdam Study. Ophthalmology. 102:1995;54-60.
42. Klein B.E.K., Klein R., Meuer S.M., Goetz L.A. Migraine headache and its association with open-angle glaucoma: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 34:1993;3024-3027.
43. Wang J.J., Mitchell P., Smith W. Is there an association between migraine headaches and open-angle glaucoma? Findings from the Blue Mountain Eye Study. Ophthalmology. 104:1997;1714-1719.
44. Wilson M.R., Hertzmark E., Walker A.M.et al. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol. 105:1987;1066-1071.
45. Perkins E.S., Phelps C.D. Open angle glaucoma, ocular hypertension, low-tension glaucoma, and refraction. Arch Ophthalmol. 100:1982;1464-1467.
46. Ponte F., Giuffre G., Giammanco R., Dardononi G. Risk factors of ocular hypertension and glaucoma: the Casteldaccia Eye Study. Doc Ophthalmol. 85:1994;203-210.
47. Stoilova D., Child A., Trivan O.C., Crick R.P., Coakes R.L., Sarfarazi M. Localization of a locus (GLC1B) for adult-onset primary open angle glaucoma to the 2 cen-q13 region. Genomics. 36:1996;142-150.
48. Stone E.M., Fingert J.H., Alward W.L.M.et al. Identification of a gene that causes primary open angle glaucoma. Science. 275:1997;668-670.
49. Wirtz M.K., Samples J.R., Kramer P.L.et al. Mapping a gene for adult-onset primary open angle glaucoma to chromosome 3q. Am J Hum Genet. 60:1997;296-304.
50. Trifan O.C., Traboulsi E.I., Stoilova D.et al. The third locus (GLC1D) for adult-onset primary open angle glaucoma maps to the 8q23 region. Am J Ophthalmol. 126:1998;17-28.
51. Sarfarazi M., Child A., Stoilova D.et al. Localization of the fourth locus (GLC1E) for adult-onset primary open angle glaucoma to the 10p15-p14 region. Am J Hum Genet. 62:1998;641-652.
52. Wirtz M.K., Samples J.R., Rust K.et al. GLC1F, a new primary open-angle glaucoma locus, maps to 7q35-q36. Arch Ophthalmol. 117:1999;237-241.
53. Grant W.M., Burke J.F. Why do some people go blind from glaucoma? Ophthalmology. 89:1982;991-998.
54. Nygaard H.A., Hovding G. Adverse effects of local use of beta-blocker in glaucoma: a literature review and a survey of reports and the adverse drug reaction authority 1986-95. Tidsskr Nor Laegeforen. 117:1997;2019-2021.
55. Zimmerman T.J., Kooner K.S., Kandarakis A.S., Ziegler L.P. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol. 102:1984;551-553.
56. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-up Study: 7. Results. Am J Ophthalmol. 120:1995;718-731.
57. The Advanced Glaucoma Intervention Study (AIS): 4. Comparison of treatment outcomes within race: 7-year results. Ophthalmology. 105:1998;1146-1164.
58. Jay J.L., Allan D. The benefit of early trabeculectomy versus conventional management in primary open-angle glaucoma relative to severity of disease. Eye. 3:1989;528-535.
59. Migdal C., Gregory W., Hitching R. Long term financial outcome after early surgery compared with laser and medicine in open-angle glaucoma. Ophthalmology. 101:1994;1651-1657.
60. Five-year follow-up of the Fluorouracil Filtering Surgery Study. Am J Ophthalmol. 121:1996;349-366.
61. Singh K., Egbert P.R., Byrd S.et al. Trabeculectomy with intraoperative 5-fluorouracil vs mitomycin C. Am J Ophthalmol. 123:1997;48-53.
62. Molteno A.C.B., Van Rooyen M.M.B., Bartholomew R.S. Implants for draining neovascular glaucoma. Br J Ophthalmol. 61:1977;120-125.
63. Netland P.A., Chaturvedi N., Dreyer E.B. Calcium channel blockers in the management of low tension and open-angle glaucoma. Am J Ophthalmol. 115:1993;608-613.
64. Kitazawa Y., Shirai H., Go F.J. The effect of Ca2(+)-antogonist on visual field in low-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 227:1989;408-412.
65. Caprioli J. Neuroprotection of the optic nerve in glaucoma. Acta Ophthalmologica. 75:1997;364-367.
66. Hepler R.S.et al. Marihuana smoking and intraocular pressure. JAMA. 217:1971;1392.
67. Preferred practice pattern of primary angle-closure glaucoma. 1996;American Academy of Ophthalmology, San Francisco.
68. Congdon N.G., Quigley H.A., Hung P.T., Wang H., Ho T.C. Screening techniques for angle-closure glaucoma in rural Taiwan. Acta Ophthalmol Scand. 74:1996;113-119.
69. Lowe R.F. Treatment for primary creeping (chronic) angle closure glaucoma. Asian Pac J Ophthalmol. 2:1990;91.
70. West R.H. Creeping angle closure glaucoma, the influence of iridotomy and iridectomy. Aust NZJ Ophthalmol. 20:1992;23-38.
71. Alsbirk P.H. Primary angle closure glaucoma: oculometry, epidemiology and genetics in a high-risk population. Arch Ophthalmol. 54:1976;5-31.
72. Hu Z., Zhao Z.L., Dong F.T.et al. An epidemiologic investigation of glaucoma in Beijing and Shun-yi County. Chin J Ophthalmol. 22:1989;301-306.
73. Seah S.K.L., Foster P.J., Chew P.T.K.et al. Incidence of acute primary angle-closure glaucoma in Singapore: an island-wide survey. Arch Ophthalmol. 115:1997;1436-1440.
74. Jacob A., Thomas R., Koshi S.P., Braganza A., Muliyil J. Prevalence of primary glaucoma in an urban south Indian population. Indian J Ophthalmol. 46:1998;81-86.
75. Graham P., Hollows F. Intra-ocular pressure, glaucoma and glaucoma suspects in a defined population. Br J Ophthalmol. 50:1966;570-586.
76. Arkell S.M., Lightman D.A., Sommer A.et al. The prevalence of glaucoma among Eskimos of NW Alaska. Arch Ophthalmol. 105:1987;482-485.
77. Lim A.S.M. PACG in Singapore. Aust J Ophthalmol. 7:1979;23-30.
78. Erie J.C., Hodge D.O., Gray D.T. The incidence of primary angle-closure glaucoma in Olmsted County, Minnesota. Arch Ophthalmol. 115:1997;177-181.
79. Congdon N., Wang F., Tielsch J.M. Issues in the epidemiology and population-based screening of primary angle-closure glaucoma. Surv Ophthalmol. 36:1992;411-423.
80. Sun S.J., Guan J.X., Hu R.H., Wang X.Y. A statistical and family-history-based analysis of primary glaucoma. Chin J Ophthalmol. 21:1985;32-34.
81. Cox J.E. Angle closure glaucoma among the Alaskan Eskimos. Glaucoma. 6:1984;135-137.
82. Lowe R.F. Primary angle-closure glaucoma: a reveiw of ocular biometry. Aust J Ophthalmol. 5:1977;9-17.
83. McHomey C.A., Ware J.E. Jr., Raczek A.E. The MOS 36-item short-form health survey (SF-36): II psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 31:1993;247-263.
84. Leske MC, Heijl A, Hyman L, Bengtsson B, and the Elderly Manifest Glaucoma Trial Group. Early manifest glaucoma trial: design and baseline data. Ophthalmology (in press).
85. Musch D.C., Lichter P.R., Guire K.E., Standardi C.L. The Collaborative Initial Glaucoma Treatment Study: study design, methods, and baseline characteristics of enrolled patients. Ophthalmology. 106:1999;653-662.
86. Gordon M.O., Kass M.A. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol. 117:1999;573-583.